Apollo Hospitals To Roll Out Sputnik V Covid Vaccine At ₹ 1,195

Apollo Group of Hospitals has announced that it will start administering the Sputnik V vaccine, across its hospitals in India from the second week of June. The vaccine will be priced at ₹ 1,195 per dose.

In a statement, Executive Vice-chairperson Shobana Kamineni of the Apollo Group of Hospitals said that the group has completed administering one million vaccine doses across 80 locations in India, and will prioritise frontline workers, high-risk population, and corporate employees.

Giving details on ramping up their vaccination programme, Kamineni said, “In June, we will do a million every week and double that in July. We are on track to complete 20 million jabs by September this year.”

As reported earlier, India and Russia are planning to manufacture around 35-40 million doses every month that will start from August or September.

On May 24, the Russian Direct Investment Fund (RDIF) and Panacea Biotec, one of the leading pharmaceutical producers in India, had launched the production of the Sputnik V Covid-19 vaccine.

Sputnik V got approval from the Subject expert committee (SEC) for Emergency Use Authorisation (EUA), making it the third COVID-19 vaccine to get clearance in India.

India has become the 60th country to authorise the use of the Russian vaccine against coronavirus.

Under the Centre’s liberalised vaccination policy, the private sector hospitals have earned a crucial role as they can directly procure the doses from manufacturers and administer them to the eligible beneficiaries. The beneficiaries, however, need to register themselves for the jabs through the CoWin platform.

Sputnik V was registered in India under emergency use authorization procedure on April 12 and vaccination against coronavirus with the Russian vaccine started on May 14.

The government is also hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country’s vaccination drive, sources said on Thursday.

An application seeking regulatory approval for Sputnik Light is expected to be filed in the next couple of weeks and it could become the first single-dose vaccine to be launched in India.

Facebook Comments